Uncategorized
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and Chief Executive Officer Todd C. Brady, M.D., Ph.D. will participate in analyst-led fireside conversations at the BTIG Virtual Biotechnology Conference and the H.C. Wainwright Ophthalmology Virtual Conference. BTIG Virtual Biotechnology Conference Date: Monday, August 9, 2021 Time: 9:30 a.m. ET H.C. Wainwright Ophthalmology Virtual Conference Date: Tuesday, August 17, 2021 Ti